- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ocugen, Inc (OCGN)
Assess today's live Ocugen, Inc (OCGN) share price, performance and insights using our live NASDAQ: OCGN stock exchange data.
Analyse the historical data and Ocugen, Inc share price performance charts on this page. Our technical summary section provides analysis on Ocugen share price buy/sell indicators using real-time data (or discuss the Ocugen (OCGN) stock price today with other investors in the Ocugen NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ OCGN share price (ISIN: US67577C1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Ocugen, Inc Share Price Today?
The Ocugen share price today is 1.660.
What Is the Stock Symbol for Ocugen, Inc
The stock symbol (or 'ticker') for Ocugen, Inc is "OCGN."
What Stock Exchange Does Ocugen, Inc Trade On?
Ocugen, Inc is listed and trades on the NASDAQ stock exchange.
Is Ocugen, Inc a Good Stock to Buy?
Determining whether Ocugen, Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Ocugen, Inc share price performance charts on this page. Our technical summary section provides analysis on Ocugen share price buy/sell indicators using real-time data (or discuss the Ocugen (OCGN) stock price today with other investors in the Ocugen NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ OCGN share price (ISIN: US67577C1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Ocugen, Inc Share Price Today?
The Ocugen share price today is 1.660.
What Is the Stock Symbol for Ocugen, Inc
The stock symbol (or 'ticker') for Ocugen, Inc is "OCGN."
What Stock Exchange Does Ocugen, Inc Trade On?
Ocugen, Inc is listed and trades on the NASDAQ stock exchange.
Is Ocugen, Inc a Good Stock to Buy?
Determining whether Ocugen, Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.580
1.680
52 wk Range
0.640
2.725
Earnings results expected in 6 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.5801.680
52 wk Range
0.6402.725
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OCGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.571
Upside
+597.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel recombinant fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
Ocugen, Inc Earnings Call Summary for Q4/2025
- Ocugen reported Q4 2025 net loss of $0.06/share, meeting forecasts; stock fell 5.38% pre-market to $1.93 with $641M market cap.
- R&D expenses surged 28.9% YoY to $10.7M as company advances retinitis pigmentosa and Stargardt disease clinical programs.
- Company projects -$0.05 EPS quarterly for FY2026; cash runway extends into late 2026, potentially Q2 2027 with warrant exercises.
- Analyst price targets range $7-$15 despite no anticipated profitability this year; key clinical trial completions expected ahead.
- G&A expenses decreased 3.2% to $6.1M; management emphasizes long-term commercialization strategy amid ongoing losses and no revenue.
Last Updated: 04/03/2026, 15:14
Read Full TranscriptCompare OCGN to Peers and Sector
Metrics to compare | OCGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOCGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.3x | −0.9x | −0.5x | |
PEG Ratio | 0.62 | −0.23 | 0.00 | |
Price/Book | −46.2x | 2.0x | 2.6x | |
Price / LTM Sales | 127.3x | 10.5x | 3.2x | |
Upside (Analyst Target) | - | 116.1% | 47.4% | |
Fair Value Upside | Unlock | 19.4% | 7.7% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.571
(+597.07% Upside)
Earnings
Latest Release
04/03/2026
EPS / Forecast
-0.06 / -0.06
Revenue / Forecast
-193K / 1.03M
People Also Watch
FAQ
What Is the Ocugen (NASDAQ: OCGN) Share Price Today?
The Ocugen stock price today is 1.660 USD.
What Stock Exchange Does Ocugen (OCGN) Trade On?
Ocugen is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Ocugen?
The stock symbol (also called a 'ticker') for Ocugen is "OCGN."
What Is the Current Ocugen Market Capitalisation?
As of today, Ocugen (NASDAQ: OCGN) market cap is 561.940M USD.
What Is Ocugen's (OCGN) Earnings Per Share (TTM)?
The Ocugen EPS is currently -0.226 (Trailing Twelve Months).
When Is the Next Ocugen Earnings Date?
Ocugen's next earnings report will be released on 01/05/2026.
Is OCGN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Ocugen moving averages and other technical indicators, the daily buy/sell signal for OCGN stock is Strong Sell.
How Many Times Has Ocugen Stock Split?
Ocugen has split 1 times. (See the OCGN stock split history page for full effective split date and price information.)
How Many Employees Does Ocugen Have?
Ocugen has 116 employees, based on their latest Companies House report.
What is the current trading status of Ocugen (NASDAQ: OCGN)?
As of 25/04/2026, Ocugen (OCGN) is trading at a share price of 1.660 USD, with a previous close of 1.670 USD. The stock has fluctuated within a day range of 1.580 USD to 1.680 USD, while its 52-week range spans from 0.640 USD to 2.725 USD.
What Is Ocugen (OCGN) Price Target According to Analysts?
The average 12-month price target for Ocugen is 11.571 USD, with a high estimate of 22 USD and a low estimate of 7 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +597.07% Upside potential.
What Is the OCGN Premarket Price?
OCGN's last pre-market stock price is 1.660 USD. The pre-market share volume is 128,790.000, and the stock has decreased by -0.010, or -0.600%.
What Is the OCGN After Hours Price?
OCGN's last after hours stock price is 1.640 USD, the stock has decreased by -0.020, or -1.200%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.